US$ 24.32
glp-1 announcement today Announced today, effective 7/1/2026, Medicare patients will only pay $50 per month GLP-1 Pipeline Update: May 2026
Description
(1999) Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients

Buyer Takeaway: Compounded medications follow a different regulatory pathway than FDA-approved finished drug products

Moreover, the combined treatment of sDPP4 and LPS leads to increased expression and secretion of the pro-inflammatory cytokines, TNF and IL-6

Midi Health typically does not accept insurance for platform fees, though some patients can use HSAs or FSAs